Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Equity

PROSHARES TRUST (ZBIO) Assets Average: 2024-2025

Historic Assets Average for Zenas BioPharma (ZBIO) over the last 1 years, with Sep 2025 value amounting to $307.6 million.

  • Zenas BioPharma's Assets Average was N/A to $307.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $307.6 million, marking a year-over-year change of. This contributed to the annual value of $219.1 million for FY2024, which is N/A change from last year.
  • Zenas BioPharma's Assets Average amounted to $307.6 million in Q3 2025, which was down 1.87% from $313.4 million recorded in Q2 2025.
  • Zenas BioPharma's 5-year Assets Average high stood at $386.7 million for Q4 2024, and its period low was $307.6 million during Q3 2025.
  • Over the past 2 years, Zenas BioPharma's median Assets Average value was $332.6 million (recorded in 2025), while the average stood at $339.9 million.